Resumen de Seguimiento farmacoterapéutico durante la hospitalización a pacientes transplantados en la fundación clínica Valle del Lili (Cali � Colombia)
Jorge Salcedo, Natalia Agudelo, María Isabel Baena Parejo
- español
Describir la incidencia de Problemas Relacionados con los Medicamentos(PRM) en los pacientes transplantados de órganos sólidos en la Fundación Clínica Valle del Lili (FCVL) y la frecuencia de PRM resueltos en estos pacientes.
Método: Se realizó seguimiento a pacientes mayores de 18 años trasplantados de riñón o hígado durante cuatro meses de estudio, desde el ingresó del paciente a Cuidados Intensivos hasta la alta del hospital. El estudio fue cuasi - experimental sin grupo control. El seguimiento se realizó mediante la adaptación del método Dáder y utilizando la clasificación de PRM del Segundo Consenso de Granada.
Resultados: Se realizó seguimiento a 24 pacientes, 6(25%) transplantes hepáticos y 18(75%) renales. Se detectaron 18 PRM, 4(22%) en pacientes de transplante hepático y 14(78%) de renal. La incidencia de PRM por paciente fue 0,7 en transplantados de hígado y 0.8 en renales. Se detectaron 3(16,7%) PRM de necesidad, 14(77,8%) de efectividad, 1(5,5%) de seguridad. Se realizaron 18 intervenciones por parte del farmacéutico, 6(33,3%) fueron aceptadas, y en 7 (38,9%) se resolvió el problema de salud.
Conclusiones: La implantación del método Dáder para la realización de seguimiento farmacoterapéutico durante la hospitalización a pacientes transplantados de órganos sólidos permite conocer la incidencia PRM y la frecuencia de PRM resueltos en este tipo de pacientes.
- English
To describe the incidence of drugrelated problems (DRP) in patients suffering solid organ transplant at Foundation Clinic Valle del Lili (FVVL), and the frequency of resolved DRP in those patients.
Method: pharmacotherapy follow-up was provided to patients older than 18 years and kidney or liver transplanted, during four months since patient admission in the intensive care unit. The study had a quasi-experimental non controlled design. Pharmacotherapy followup was provided by adapting Dader method and using DRP classification from the Second Consensus of Granada.
Results: Pharmacotherapy follow-up was provided to 24 patients, 6(25%) liver transplanted and 14 /78%) kidney transplanted.
Incidence of DRPs per patient was 0.7 in liver transplanted and 0.8 in kidney transplanted. 3 (16.7%) necessity DRPs, 14 (77.8%) effectiveness DRP, and 1 (5.5%) safety DRPs were detected. 18 pharmacist interventions were done, 6 (33.3%) were accepted, and in 7 (38.9%) health problem was resolved.
Conclusions: Implementation of Dader method for provision of pharmacotherapy follow-up during hospital stay of solid organs transplanted patients allow to know DR incidence and frequency of resolving DRP in this patients.To describe the incidence of drugrelated problems (DRP) in patients suffering solid organ transplant at Foundation Clinic Valle del Lili (FVVL), and the frequency of resolved DRP in those patients.
Method: pharmacotherapy follow-up was provided to patients older than 18 years and kidney or liver transplanted, during four months since patient admission in the intensive care unit. The study had a quasi-experimental non controlled design. Pharmacotherapy followup was provided by adapting Dader method and using DRP classification from the Second Consensus of Granada.
Results: Pharmacotherapy follow-up was provided to 24 patients, 6(25%) liver transplanted and 14 /78%) kidney transplanted.
Incidence of DRPs per patient was 0.7 in liver transplanted and 0.8 in kidney transplanted. 3 (16.7%) necessity DRPs, 14 (77.8%) effectiveness DRP, and 1 (5.5%) safety DRPs were detected. 18 pharmacist interventions were done, 6 (33.3%) were accepted, and in 7 (38.9%) health problem was resolved.
Conclusions: Implementation of Dader method for provision of pharmacotherapy follow-up during hospital stay of solid organs transplanted patients allow to know DR incidence and frequency of resolving DRP in this patients.
